You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
ScienceInsider reports that researchers funded through the Cancer Moonshot program will have to make their papers immediately accessible to the public.
Standards for interoperability and better cooperation among stakeholders will help unleash the power of genomics in cancer care, says the head of the Biden Cancer Initiative.
Trump has repeatedly threatened to drastically slash NIH funding, but its new $37 billion budget is a historic high.
The Bidens have convened a diverse board and staff with the goal of continuing efforts to accelerate research and development begun under the Cancer Moonshot Initiative.
Discover's D-brief blog ponders the future of the Cancer Moonshot initiative.
The law contains provisions that proponents say will advance precision medicine and speed new tests to market, but critics worry if this will come at a cost to public health.
Personalized medicine proponents are uncertain where funding, personnel, and priorities will land in a new administration and Congress.
NantHealth, CHOP, and their collaborators intend to release genomic, transcriptomic, and proteomic data from 1,600 patients in the next six months
The update includes several key initiatives such as a liquid biopsy database, a DoD-led longitudinal study, and NCI cloud collaborations with Amazon and Microsoft.
Among the Blue Ribbon Panel's recommendations, several involve using molecular information to investigate the development and progression of cancer.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.